BUZZ-GeneDx plunges after trimming annual revenue forecast

GeneDx Holdings Corp. Class A

GeneDx Holdings Corp. Class A

WGS

0.00

** Shares of genomics firm GeneDx WGS.O fall 43% to $38.69 in extended trading

** Co lowers annual revenue forecast to between $475 million and $490 million, compared to previous projection of $540 million to $555 million

** Reports Q1 revenue of $102.3 million, missing analysts' average estimate of $112.96 million, according to data compiled by LSEG

** WGS down ~48% YTD


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.